Global Nanobiotechnology Consortium


        The year 2020 has seen a year of unprecedented calamity for mankind globally, with the advent of the COVID-19 pandemic, that has affected millions globally killing hundreds of thousands of individuals, and the death toll from COVID-19 continues to increase. Some have suggested that the Pandemic might continue in a certain form until 2024. There is a dire need to innovate nano-biotech-based methods and approaches for the management of the COVID-19 pandemic. A pandemic problem such as COVID-19 requires global collaboration and network and to this end the Florida Association of Nanotechnology has created a Global Nanobiotechnology Consortium (GNC). GNC plans to have its first e-Conference in March 2021.

 

 

    

 

 

     The year 2020 has seen a year of unprecedented calamity for mankind globally, with the advent of the COVID-19 pandemic, that has affected millions globally killing hundreds of thousands of individuals, and the death toll from COVID-19 continues to increase. Some have suggested that the Pandemic might continue in a certain form until 2024. There is a dire need to innovate nano-biotech-based methods and approaches for the management of the COVID-19 pandemic. Our “Global Nanobiotechnology Consortium (GNC) E-conference” focuses on the applications of nanotechnology concept in biomedical sciences, bioengineering, and medicine for COVID-19 pandemic. The conference goals are pretty much in line with one of the focus areas of biomedical engineering is defined as “Design and validation of systems that integrate living and non-living components for improved understanding, diagnosis, monitoring, and treatment of disease or injury”. The conference is motivated by the need for the development of nanobiotechnologies for current COVID-19 pandemic and such pandemics in the future.
Nanobiotechnology with a very interdisciplinary nature brings scientists from medicine to physics, material science to molecular biology, and biomedical engineering together to find solutions for challenging problems that humankind is facing with transdisciplinary approaches. It is widely believed that research into the methods of engineering nanoparticles and mechanisms of nanoparticle-mediated detection of disease cells and molecules in vitro and in vivo will be the “holy grail” of disease detection, imaging, and efficient management in the 21st century. This conference is timely in view of the current pandemic and such pandemics in the future. The role of nanotechnology has been clearly illustrated in the novel methods of diagnosis, vaccines, and treatments, which have been developed against COVID-19. To name a few examples some of the vaccines (e.g., Moderna RNA vaccine) and therapies (e.g., Remdesvir) involve nanotech-based biomedical systems. Here at the USF, the 3D printed SWAB and the electronic nose are two examples of biomedical engineering system applications to COVID-19 pandemic solutions.


      The intent of this first e-conference is to converge the thinking of global leaders of nanobiotechnology in an effort to advance the innovative solutions for their worldwide applications. The conference will feature symposia addressing advances in nanoelectronics, nanobiotechnology, biosensing, nano-diagnostics, nanoimaging, and other innovative areas of research and their applications in medicine, and pharmacy, especially as it applies to the current pandemic and such pandemics in the future. It will also provide opportunities to network with researchers from other academic institutions and the broader nanotechnology and nano pharma industry.

 

The goals are:

  • Promote collaborative and interdisciplinary research,

  • Help to create multidisciplinary education and research projects including novel approaches for translational research,

  • Host presentations by experts in creating international collaborations, start-ups for nanotech business, production scale-up, and

  • Provide new insights into nanomedicine applications for nanoscientists, clinicians and engineers in the areas of drug delivery, diagnostic testing for the pandemic and related diseases.

 


Chairs

Shyam (Sam) S. Mohapatra (Co-chair)
Director of Div of Translational Medicine and Ctr Research & Education in Nano-bioengineering, Morsani College of Medicine, The University of South Florida, Tampa, FL

 

Mustafa Culha (Co-chair)
Sabanci University Nanotechnology Research and Application Center (SUNUM) and Dept of Internal Medicine, Morsani College of Medicine, The University of South Florida, Tampa, FL



Advisory Committee

o    Ratnesh Lal, University of California-San Diego, USA  
o    Subhra Mohapatra, University of South Florida, USA
o    Fazilet Vardar Sukan, Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, Turkey
o    Donald Martin, Universite Grenoble Alpes, France
o    Robert Marks, Ben-Gurion University of the Negev, Israel
o    Rawil Fakhrullin, Kazan Federal University, Republic of Tatarstan (RF)
o    Monica Ryff Moreira Vianna, Federal University of Rio Grande, Brazil


 

 

 


Global Nanobiotechnology Consortium (GNC) E-conference

Interested in attending the GNC e-conference or presenting? Click the below button to register and submit an abstract today!

*If selected to present, individuals will be slotted for 5-10 minutes via a PPT presentation on one of the conference dates.

 

Abstract Submission Deadline: 2/22/21

Registration Deadline: 3/5/21

GNC Flyer - 3.5.21 Update.jpg
  • Instagram - White Circle
  • Facebook - White Circle

NanoFlorida 2021

Date To Be Released